Compare Freeport-McMoRan Inc (FCX) vs Teladoc Health Inc (TDOC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Freeport-McMoRan Inc vs Teladoc Health Inc — how do they compare? Freeport-McMoRan Inc trades at $72.58 (market cap $103.19B), while Teladoc Health Inc trades at $5.54 (market cap $1.01B). The key difference: Freeport-McMoRan Inc is far larger — about 102.2× Teladoc Health Inc's market cap, and Freeport-McMoRan Inc pays a 0.83% dividend while Teladoc Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Freeport-McMoRan Inc for 69 Days and Teladoc Health Inc for 39 Days on average.
| FCX | TDOC | |
|---|---|---|
Market Cap | $103.19B | $1.01B |
Volume | 11,744,911 | 3,622,440 |
Sector | Basic Materials | Health |
52-Week High | $79.91 | $9.72 |
52-Week Low | $38.65 | $4.47 |
Typical Hold Time | 69 Days | 39 Days |
Enterprise Value | $109.47B | $1.27B |
Dividend Yield | 0.83% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FCX trades at $71.13, down 1.98% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $72.27. The company has beaten earnings estimates for three consecutive quarters, with Q3 2026 results pending. Strong operating cash flow of $5.61 billion in 2025 supports ongoing expansion projects amid favorable copper demand trends.
The outlook for FCX is positive, driven by robust copper demand from AI and data center growth, but risks include rising production costs and a legal investigation. Wall Street sentiment is bullish with 61% buy ratings, though the stock faces near-term resistance at $72.
Teladoc Health (TDOC) trades at $5.54, down 3.99% in the latest session, reflecting ongoing investor concerns despite recent earnings beats. The stock shows bearish technical signals with oversold conditions while fundamentals reveal a mixed picture - strong gross margins of 68.97% but persistent net losses. Recent management changes and legal investigations add uncertainty, though the company maintains solid cash flow from operations of $294.36 million.
TDOC presents a high-risk opportunity with significant upside potential given the $8.83 consensus price target, representing 59% upside. However, continued net losses, negative cash flow trends, and competitive pressures in telehealth create substantial execution risk. The stock's current valuation at 0.4x sales appears attractive if the company can achieve profitability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Freeport-McMoRan Inc
Freeport-McMoRan Inc is an international mining company. It operates geographically diverse assets with proven and probable mineral reserves of copper, gold and molybdenum. The company's portfolio of assets includes the Grasberg minerals district in Indonesia
Read more on FCX →About Teladoc Health Inc
Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.
Read more on TDOC →
